RecruitingNot ApplicableNCT06815107

Risk Factors for Poor Tolerance of Ureteral Double-J Stent


Sponsor

Centre Hospitalier Universitaire, Amiens

Enrollment

200 participants

Start Date

Apr 15, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The placement of a Ureteral Double-J Stent as an emergency treatment or preparation for endoscopy after Colic nephritis is very frequent. It is often poorly supported, most often by young patients. A rich symptomatology is related to the probe responsible for a limitation of activities that can have a strong socio-economic impact. The objective of this study is the identification of the predictive factors of poor tolerance.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • patient over 18 years old
  • patient who need Ureteral Double-J Stenting

Exclusion Criteria7

  • patient under 18 years old,
  • Iterative change,
  • understanding disorder,
  • inability to answer the questionnaire,
  • refusal of the patient,
  • long-term Ureteral Double-J Stenting (more than 6 month),
  • active cancer.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERquestionnary

On day 1 of an ureteral double J stenting, each participant will receive the first USSQ questionnaire, in the French validated version. This questionnaire will be completed at home, one week after the intervention and returned at the following consultation or hospitalization.

OTHERUSSQ survey

if the stent is removed less than 6 months later, the second USSQ survey, in the French validated version will be given to the patient when removing the stent. This questionnaire will be completed at home one week after removal of the stent and return to the referent hospital. If the patient does not return the second questionnaire, our team may contact them by phone to complete it.


Locations(1)

CHU Amiens-Picardie

Amiens, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06815107


Related Trials